Page 2512 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 152 Hematologic Manifestations of Childhood Illness 2237.e7

284. Fluss J, Geary D, Deveber G: Cerebral sinovenous thrombosis and 306. Lee AY, Levine MN, Baker RI, et al: Low-molecular-weight heparin
idiopathic nephrotic syndrome in childhood: report of four new cases versus a coumarin for the prevention of recurrent venous thromboem-
and review of the literature. Eur J Pediatr 165(10):709–716, 2006. bolism in patients with cancer. N Engl J Med 349(2):146–153, 2003.
285. Kerlin BA, Ayoob R, Smoyer WE: Epidemiology and pathophysiology 307. Grace RF, Dahlberg SE, Neuberg D, et al: The frequency and manag-
of nephrotic syndrome-associated thromboembolic disease. Clin J Am ment of asparaginase-related thrombosis in paediatric and adult patients
Soc Nephrol 7(3):513–520, 2012. with acute lymphoblastic leukaemia treated on Dana-Farber Cancer
286. Monagle P, Chalmers E, Chan A, et al: Antithrombotic therapy Institute consortium protocols. Br J Haematol 152:452–459, 2011.
in neonates and children: American College of Chest Psysicians 308. Sweet SC, Wong HH, Webber SA, et al: Pediatric transplantation in
Evidence-Based Clinical Practice Guildelines (8th Edition). Chest 133(6 the United States, 1995-2004. Am J Transplant 6(5 Pt 2):1132–1152,
Suppl):887S–968S, 2008. 2006.
287. Levy DM, Massicotte MP, Harvey E, et al: Thromboembolism in 309. Kim JJ, Marks SD: Long-term outcomes of children after solid organ
paediatric lupus patients. Lupus 12(10):741–746, 2003. transplantation. Clinics (Sao Paulo) 69(Suppl 1):28–38, 2014.
288. Cervera R, Khamashta MA, Font J, et al: Morbidity and mortality in 310. Kelly DA: Current issues in pediatric transplantation. Pediatr Transplant
systemic lupus erythematosus during a 10-year period: a comparison 10(6):712–720, 2006.
of early and late manifestations in a cohort of 1,000 patients. Medicine 311. Marinella MA: Hematologic abnormalities following renal transplanta-
(Baltimore) 82(5):299–308, 2003. tion. Int Urol Nephrol 42(1):151–164, 2010.
289. Avcin T, Cimaz R, Silverman ED, et al: Pediatric antiphospholipid 312. Iglesias-Berengue J, Lopez-Espinosa JA, Ortega-Lopez J, et al: Hema-
syndrome: clinical and immunologic features of 121 patients in an tologic abnormalities in liver-transplanted children during medium- to
international registry. Pediatrics 122(5):e1100–e1107, 2008. long-term follow-up. Transplant Proc 35(5):1904–1906, 2003.
290. Wahl DG, Guillemin F, de Maistre E, et al: Risk for venous 313. Dobrolet NC, Webber SA, Blatt J, et al: Hematologic abnormalities
thrombosis related to antiphospholipid antibodies in systemic lupus in children and young adults receiving tacrolimus-based immunosup-
erythematosus—a meta-analysis. Lupus 6(5):467–473, 1997. pression following cardiothoracic transplantation. Pediatr Transplant
291. Cimaz R, Descloux E: Pediatric antiphospholipid syndrome. Rheum Dis 5(2):125–131, 2001.
Clin North Am 32(3):553–573, 2006. 314. Yorgin PD, Belson A, Sanchez J, et al: Unexpectedly high prevalence
292. Male C, Mitchell LG, Julian JA, et al: Acquired activated protein of posttransplant anemia in pediatric and young adult renal transplant
C resistance is associated with lupus anticoagulants and thrombotic recipients. Am J Kidney Dis 40(6):1306–1318, 2002.
events in pediatric patients with systemic lupus erythematosus. Blood 315. Al-Uzri A, Yorgin PD, Kling PJ: Anemia in children after transplanta-
97(4):844–849, 2001. tion: etiology and the effect of immunosuppressive therapy on eryth-
293. Male C, Foulon D, Hoogendoorn H, et al: Predictive value of persistent ropoiesis. Pediatr Transplant 7(4):253–264, 2003.
versus transient antiphospholipid antibody subtypes for the risk of 316. Maheshwari A, Mishra R, Thuluvath PJ: Post-liver-transplant anemia:
thrombotic events in pediatric patients with systemic lupus erythema- etiology and management. Liver Transpl 10(2):165–173, 2004.
tosus. Blood 106(13):4152–4158, 2005. 317. Misra S, Moore TB, Ament ME, et al: Profile of anemia in children
294. Schmugge M, Revel-Vilk S, Hiraki L, et al: Thrombocytopenia and after liver transplantation. Transplantation 70(10):1459–1463, 2000.
thromboembolism in pediatric systemic lupus erythematosus. J Pediatr 318. Embleton ND, O’Sullivan JJ, Hamilton JR, et al: High prevalence
143(5):666–669, 2003. of anemia after cardiac transplantation in children. Transplantation
295. Berube C, Mitchell LG, Silverman E, et al: The relationship of 64(11):1590–1594, 1997.
antiphospholipid antibodies to thromboembolic events in pediatric 319. Petz LD: Immune hemolysis associated with transplantation. Semin
patients with systemic lupus erythematosus: a cross-sectional study. Hematol 42(3):145–155, 2005.
Pediatr Res 44(3):351–356, 1998. 320. Ramsey G: Red cell antibodies arising from solid organ transplants.
296. Ahluwalia J, Singh S, Naseem S, et al: Antiphospholipid antibodies in Transfusion 31(1):76–86, 1991.
children with systemic lupus erythematosus: a long-term clinical and 321. Nadarajah L, Ashman N, Thuraisingham R, et al: Literature review of
laboratory follow-up status study from northwest India. Rheumatol Int passenger lymphocyte syndrome following renal transplantation and
34(5):669–673, 2014. two case reports. Am J Transplant 13(6):1594–1600, 2013.
297. Manco-Johnson MJ: How I treat venous thrombosis in children. Blood 322. Rerolle JP, Akposso K, Lerolle N, et al: Tacrolimus-induced hemolytic
107(1):21–29, 2006. uremic syndrome and end-stage renal failure after liver transplantation.
298. Monagle P, Chan A, Massicotte P, et al: Antithrombotic therapy in Clin Transplant 14(3):262–265, 2000.
children: the Seventh ACCP Conference on Antithrombotic and 323. Qu L, Kiss JE: Thrombotic microangiopathy in transplantation and
Thrombolytic Therapy. Chest 126(3):645S, 2004. malignancy. Semin Thromb Hemost 31(6):691–699, 2005.
299. Kenet G, Aronis S, Berkun Y, et al: Impact of persistent antiphospho- 324. Singh N, Gayowski T, Marino IR: Hemolytic uremic syndrome in
lipid antibodies on risk of incident symptomatic thromboembolism in solid-organ transplant recipients. Transpl Int 9(1):68–75, 1996.
children: a systematic review and meta-analysis. Semin Thromb Hemost 325. Zuber J, Le Quintrec M, Sberro-Soussan R, et al: New insights into
37(7):802–809, 2011. postrenal transplant hemolytic uremic syndrome. Nat Rev Nephrol
300. Crowther MA, Ginsberg JS, Julian J, et al: A comparison of two 7(1):23–35, 2011.
intensities of warfarin for the prevention of recurrent thrombosis in 326. Fortin MC, Raymond MA, Madore F, et al: Increased risk of throm-
patients with the antiphospholipid antibody syndrome. N Engl J Med botic microangiopathy in patients receiving a cyclosporin-sirolimus
349(12):1133–1138, 2003. combination. Am J Transplant 4(6):946–952, 2004.
301. Finazzi G, Marchioli R, Brancaccio V, et al: A randomized clinical trial 327. Liem RI, Anand R, Yin W, et al: Risk factors for chronic anemia in
of high-intensity warfarin vs. conventional antithrombotic therapy for pediatric orthotopic liver transplantation: analysis of data from the
the prevention of recurrent thrombosis in patients with the antiphos- SPLIT registry. Pediatr Transplant 16(2):137–143, 2012.
pholipid syndrome (WAPS). J Thromb Haemost 3(5):848–853, 2005. 328. Kausman JY, Powell HR, Jones CL: Anemia in pediatric renal transplant
302. Berman H, Rodriguez-Pinto I, Cervera R, et al: Pediatric catastrophic recipients. Pediatr Nephrol 19(5):526–530, 2004.
antiphospholipid syndrome: descriptive analysis of 45 patients from the 329. Misra S, Moore TB, Ament ME, et al: Red cell aplasia in children on
“CAPS Registry”. Autoimmunity Rev 13(2):157–162, 2014. tacrolimus after liver transplantation. Transplantation 65(4):575–577,
303. Raffini L, Trimarchi T, Beliveau J, et al: Thromboprophylaxis in a 1998.
pediatric hospital: a patient-safety and quality-improvement initiative. 330. Bardet V, Pissaia A, Coste J, et al: Impaired erythropoietin production
Pediatrics 127(5):e1326–e1332, 2011. in liver transplant recipients: the role of calcineurin inhibitors. Liver
304. Bajzar L, Chan AK, Massicotte MP, et al: Thrombosis in children with Transplant 12(11):1649–1654, 2006.
malignancy. Curr Opin Pediatr 18(1):1–9, 2006. 331. Schoettler M, Elisofon SA, Kim HB, et al: Treatment and outcomes of
305. Wiernikowski JT, Athale UH: Thromboembolic complications in immune cytopenias following solid organ transplant in children. Pediatr
children with cancer. Thromb Res 118(1):137–152, 2006. Blood Cancer 62:214, 2015.